W. Meinhardt et al., COMPARISON OF A MIXTURE OF PAPAVERINE, PHENTOLAMINE AND PROSTAGLANDINE(1) WITH OTHER INTRACAVERNOUS INJECTIONS, European urology, 26(4), 1994, pp. 319-321
Objective: evaluation of a self-injection program with a mixture of pa
paverine, phentolamine and prostaglandin E(1) (PGE(1)). Method: a self
-injection program for erectile dysfunction was started by 48 patients
, using a 1-ml mixture of 4.5 mg papaverine, 0.2 mg phentolamine and 1
.5 mu g PGE(1). Patients completed a questionnaire at 6 weeks and at 3
months and were followed at the Outpatients Department for an average
of 1 year. Result: of these patients 25 had previous experience with
20 mu g PGE(1) for intracavernous use and 22 patients had previously u
sed 30 mg papaverine with 1 mg phentolamine. None of these 3 self-inje
ction drugs is obviously superior in its ability to induce erections.
Priapism occurred twice on a total of 1,290 injections. After 1-year f
ollow-up, 4 patients had developed problems with fibrosis of the corpo
ra, 2 of whom had encountered this problem also in a previous self-inj
ection program. Conclusion: this triple mixture has the disadvantage o
f causing fibrosis and priapism in susceptible patients.